1. Tarka 240 mg/4 mg tablete s podaljšanim sproščanjem

Tarka 240 mg/4 mg tablete s podaljšanim sproščanjem

Trandolapril + verapamil

General information

Drug nameTarka 240 mg/4 mg tablete s podaljšanim sproščanjem
Medicine nameTrandolapril + verapamil
National drug code3002852
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupChemical Medicinal Product
OriginatorYes
Orphan drugNo

Marketing authorization

Procedure typePrenos dovoljenja za promet
No. and date of decision/certificate103-48/2022-15, 9. 11. 2022
Authorization validity dateUntil further notice
Marketing end date—
Application type—
Authorization/certificate holderViatris Healthcare Limited

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

CCARDIOVASCULAR SYSTEM
C09AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09BAce inhibitors, combinations
C09BBACE inhibitors and calcium channel blockers
C09BB10trandolapril and verapamil

Route of administration

Route of administration name
Peroralna uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

Temporary supply disruption of the medicinal product.

Last drug update date:9. 7. 2026
TEST APPLICATION